Try our corporate solution for free!
+1 (212) 419-5770
support@statista.com

Current and future value for pure play pharmaceutical companies 2005-2013

This graph shows the current and future value for pure play pharmaceutical peer set from 2005 to 2013. The future value followed a constant downwards trend. In 2007, the future value increased some 255 billion dollars. After that, since 2008, the future value decreased constantly.

Current and future value for pure play pharmaceutical peer set from 2005 to 2013 (in billion U.S. dollars)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2014

Region

Worldwide

Survey time period

2005 to October 2013

Supplementary notes

* 16 pure play biopharma companies only. Japanese companies have March year end (YE12 = Mar-13). Constant USD FOREX used from December 2012.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.